Genome-to-Treatment and Begin Newborn Genomic Screening: A Review of System Guides for the Acute Management and Newborn Screening Follow-up of Genetic Disorders in Infants and Children

Main Article Content

Laurie D. Smith Mary J. Willis Annette Feigenbaum Gunter Scharer Rebecca Mardach Christian Hansen Stephen F. Kingsmore


Many rare genetic conditions have effective interventions; however, without timely implementation, these conditions can progress to severe morbidity and even mortality. For the most relentlessly progressive conditions, a rapid molecular diagnosis alone is not sufficient to improve outcomes in these conditions. Frontline physicians are frequently unfamiliar with many of these conditions and their treatments. Additionally, the field of genetics is rapidly expanding and new conditions along with new interventions are being increasingly described. Here we present a review of the development and use of two linked automated systems developed to help overcome this problem. The first, GTR X (gene to treatment) has been developed to assist with the management of the acutely ill neonate infant or child in the neonatal or pediatric intensive care unit found to have a recognized genetic disease. Subsequently with expansion of newborn screening to potentially involve rapid next generation sequencing of newborns in parallel with the current analyte based newborn screening, we have developed an additional system, BeginNGS, intended to be used with currently available ACTion (ACT) sheets that will address both recommended confirmatory testing and initial interventions, particularly focusing on conditions that are not amenable to conventional newborn screening.

Keywords: Genetic Disorders in Infants and Children, Genome-to-Treatment

Article Details

How to Cite
SMITH, Laurie D. et al. Genome-to-Treatment and Begin Newborn Genomic Screening: A Review of System Guides for the Acute Management and Newborn Screening Follow-up of Genetic Disorders in Infants and Children. Medical Research Archives, [S.l.], v. 11, n. 10, oct. 2023. ISSN 2375-1924. Available at: <>. Date accessed: 11 dec. 2023. doi:
Research Articles


1. OMIM. OMIM - Online Mendelian Inheritance in Man. Published 2019.

2. Willig LK, Petrikin JE, Smith LD, et al. Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings. The Lancet Respiratory Medicine. 2015; 3 (5):377-387. doi:

3. Petrikin JE, Cakici JA, Clark MM, et al. The NSIGHT1-randomized controlled trial: rapid whole-genome sequencing for accelerated etiologic diagnosis in critically ill infants. npj Genomic Medicine. 2018; 3(1). doi:

4. Farnaes L, Hildreth A, Sweeney NM, et al. Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization. npj Genomic Medicine. 2018; 3(1). doi:

5. Sanford EF, Clark MM, Farnaes L, et al. Rapid Whole Genome Sequencing Has Clinical Utility in Children in the PICU*. Pediatric Critical Care Medicine. 2019; 20 (11):1007-1020. doi: pcc.0000000000002056

6. Kingsmore SF, Henderson A, Owen MJ, et al. Measurement of genetic diseases as a cause of mortality in infants receiving whole genome sequencing. npj Genomic Medicine. 2020;5(1):1-10. doi:

7. Dimmock DP, Clark MM, Gaughran M, et al. An RCT of Rapid Genomic Sequencing among Seriously Ill Infants Results in High Clinical Utility, Changes in Management, and Low Perceived Harm. The American Journal of Human Genetics. 2020; 107 (5):942-952. doi:

8. Arar N, Seo J, Abboud HE, Parchman M, Noel P. Providers’ behavioral beliefs regarding the delivery of genomic medicine at the Veterans Health Administration. Personalized Medicine. 2010; 7(5):485-494. doi:

9. Selkirk CG, Weissman SM, Anderson A, Hulick PJ. Physicians’ Preparedness for Integration of Genomic and Pharmacogenetic Testing into Practice within a Major Healthcare System. Genetic Testing and Molecular Biomarkers. 2013; 17 (3):219-225. doi:

10. Mladenić T, Mavrinac M, Dević Pavlić S, et al. Non-genetic physicians’ knowledge, attitudes and behavior towards medical genetics. Wiener Klinische Wochenschrift. 2023; [published online ahead of print, 2023 Feb 10]. doi:

11. Levy HL, LaFranchi S, Speiser P, et al. ACT Sheets and Algorithms. Published 2023.

12. Bick D, Jones M, Taylor SL, Taft RJ, Belmont J. Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseases. Journal of Medical Genetics. 2019; 56 (12):783-791. doi:

13. Ferreira CR. The burden of rare diseases. American Journal of Medical Genetics. 2019; 179(6):885-892. doi:

14. Kingsmore SF, Nanda Ramchandar, James KN, et al. Mortality in a neonate with molybdenum cofactor deficiency illustrates the need for a comprehensive rapid precision medicine system. Cold Spring Harbor molecular case studies. 2020; 6 (1):a004705-a004705. doi: 004705

15. Petrikin JE, Willig LK, Smith LD, Kingsmore SF. Rapid whole genome sequencing and precision neonatology. Seminars in Perinatology. 2015; 39 (8):623-631. doi:

16. Kingsmore SF, Cakici JA, Clark MM, et al. A Randomized, Controlled Trial of the Analytic and Diagnostic Performance of Singleton and Trio, Rapid Genome and Exome Sequencing in Ill Infants. The American Journal of Human Genetics. 2019; 105(4):719-733. doi: 2019.08.009

17. Clark MM, Hildreth A, Batalov S, et al. Diagnosis of genetic diseases in seriously ill children by rapid whole-genome sequencing and automated phenotyping and interpretation. Science Translational Medicine. 2019; 11 (489). doi:

18. Bamborschke D, Özdemir Ö, Kreutzer M, et al. Ultra‐rapid emergency genomic diagnosis of Donahue syndrome in a preterm infant within 17 hours. American Journal of Medical Genetics Part A. 2020; 185 (1):90-96. doi:

19. Dimmock D, Caylor S, Waldman B, et al. Project Baby Bear: Rapid precision care incorporating rWGS in 5 California children’s hospitals demonstrates improved clinical outcomes and reduced costs of care. The American Journal of Human Genetics. 2021; 108 (7):1231-1238. doi:

20. Wojcik MH, Fishler KP, Chaudhari BP. Re: “Next generation sequencing in neonatology: what does it mean for the next generation?” Human Genetics. 2022; 142 (2):161-164. doi:

21. Reiff M, Ross K, Mulchandani S, et al. Physicians’ perspectives on the uncertainties and implications of chromosomal microarray testing of children and families. Clinical Genetics. 2013; 83 (1):23-30. doi:

22. Shah M, Arthavan Selvanathan, Gareth Baynam, et al. Paediatric genomic testing: Navigating genomic reports for the general paediatrician. Journal of Paediatrics and Child Health. 2021; 58 (1):8-15. doi:

23. Bansal S, Kasturi K, Chin V. National Survey Assessment of the United States’ Pediatric Residents’ Knowledge, Attitudes, and Practices Regarding Newborn Screening. International Journal of Neonatal Screening. 2018; 5 (1):3. doi:

24. Musunuru K, Hershberger RE, Day SM, et al. Genetic Testing for Inherited Cardiovascular Diseases: A Scientific Statement From the American Heart Association. Circulation: Genomic and Precision Medicine. 2020; 13 (4). doi:

25.Johnson LM, Valdez JM, Quinn EA, et al. Integrating next-generation sequencing into pediatric oncology practice: An assessment of physician confidence and understanding of clinical genomics. Cancer. 2017;123(12):2352-2359. doi:

26. Marchetti F, Corsello G. Genetics and”democracy”. Italian Journal of Pediatrics. 2022; 48(1). doi:

27. Salciccioli KB, Oluyomi A, Lupo PJ, Ermis PR, Lopez KN. A model for geographic and sociodemographic access to care disparities for adults with congenital heart disease. Congenital Heart Disease. 2019; 14(5):752-759. doi:

28. Grineski SE, Morales DX, Collins TW, Wilkes J, Bonkowsky JL. Geographic and Specialty Access Disparities in US Pediatric Leukodystrophy Diagnosis. The Journal of Pediatrics. 2020; 220 (220):193-199. doi:

29. Owen MJ, Lefebvre S, Hansen C, et al. An automated 13.5 hour system for scalable diagnosis and acute management guidance for genetic diseases. Nature Communications. 2022; 13 (1):4057. doi:

30. Harding B, Webber C, Rühland L, et al. Bridging the gap in genetics: a progressive model for primary to specialist care. BMC Medical Education. 2019; 19 (1). doi:

31. Kingsmore SF, Smith LD, Kunard CM, et al. A genome sequencing system for universal newborn screening, diagnosis, and precision medicine for severe genetic diseases. The American Journal of Human Genetics. 2022; 109 (9):1605-1619. doi:

32. Adhikari AN, Gallagher RC, Wang Y, et al. The role of exome sequencing in newborn screening for inborn errors of metabolism. Nature Medicine. 2020; 26 (9):1392-1397. doi:

33. Woerner AC, Gallagher RC, Vockley J, Adhikari AN. The Use of Whole Genome and Exome Sequencing for Newborn Screening: Challenges and Opportunities for Population Health. Frontiers in Pediatrics. 2021; 9 (9). doi:

34. Bodian DL, Klein E, Iyer RK, et al. Utility of whole-genome sequencing for detection of newborn screening disorders in a population cohort of 1,696 neonates. Genetics in Medicine. 2015; 18 (3):221-230. doi:

35. Ding Y, Owen M, Le J, et al. Scalable, high quality, whole genome sequencing from archived, newborn, dried blood spots. npj Genomic Medicine. 2023; 8(1). doi:

36. Huang X, Wu D, Zhu L, et al. Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonates. Orphanet Journal of Rare Diseases. 2022; 17(1). doi:

37. Wolters Kluwer. UpToDate: Evidence-based Clinical Decision Support. Published 2023.

38. Sutton R, Pincock D. An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digital Medicine. 2020; 3 (1):1-10. doi:

39. Frisinger A, Papachristou P. The voice of healthcare: introducing digital decision support systems into clinical practice - a qualitative study. BMC Primary Care. 2023; 24 (1). doi:

40. Bick D, Bick SL, Dimmock DP, Fowler TA, Caulfield MJ, Scott RH. An online compendium of treatable genetic disorders. American Journal of Medical Genetics Part C, Seminars in Medical Genetics. 2021; 187 (1):48-54. doi:

41. Bick D, Bick SL, Dimmock DP, Fowler TA, Caulfield MJ, Scott RH. Search for treatments for genetic disorders - Treatments for genetic disorders. Published December 2021.

42. Atalaia A, Thompson R, Corvo A, et al. A guide to writing systematic reviews of rare disease treatments to generate FAIR-compliant datasets: building a Treatabolome. Orphanet Journal of Rare Diseases. 2020; 15(1). doi:

43. Sayers EW, Beck J, Brister JR, et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Research. 2019; 48 (D1):D9-D16. doi:

44. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics. 2009; 42 (2):377-381. doi:

45. Therrell BL, Padilla CD, Loeber JG, et al. Current status of newborn screening worldwide: 2015. Seminars in Perinatology. 2015; 39 (3):171-187. doi:

46. American Academy of Pediatrics. Newborn Screening: A Blueprint for the Future Executive Summary: Newborn Screening Task Force Report. Pediatrics. 2000; 106 (Supplement_2):386-388. doi:

47. Kayki-Mutlu G, Aksoyalp ZS, Wojnowski L, Michel MC. A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021. Naunyn-Schmiedeberg’s Archives of Pharmacology. 2022; 395 (8):867-885. doi:

48. Sontag MK, Yusuf C, Grosse SD, et al. Infants with Congenital Disorders Identified Through Newborn Screening — United States, 2015–2017. MMWR Morbidity and Mortality Weekly Report. 2020; 69(36):1265-1268. doi:

49. Center for Disease Control and Prevention CDC. Impact of expanded newborn screening--United States, 2006. PubMed. 2008; 57 (37):1012-1015.

50. Downie L, Halliday J, Lewis S, Amor DJ. Principles of Genomic Newborn Screening Programs: A Systematic Review. JAMA Netw Open. 2021; 4 (7):e2114336.

51. Moultrie R, Paquin RS, Rini C, et al. Parental Views on Newborn Next Generation Sequencing: Implications for Decision Support. Maternal and Child Health Journal. 2020; 24 (7):856-864. doi:

52. Mandrell BN, Gattuso JS, Pritchard M, et al. Knowledge Is Power: Benefits, Risks, Hopes, and Decision-Making Reported by Parents Consenting to Next-Generation Sequencing for Children and Adolescents with Cancer. Seminars in Oncology Nursing. 2021; 37 (3):151167. doi:

53. Jaitovich Groisman I, Hurlimann T, Godard B. Parents of a child with epilepsy: Views and expectations on receiving genetic results from Whole Genome Sequencing. Epilepsy & Behavior. 2019; 90: 178-190. doi:

54. Lopez Santibanez Jacome L, Dellefave‐Castillo LM, Wicklund CA, et al. Practitioners’ Confidence and Desires for Education in Cardiovascular and Sudden Cardiac Death Genetics. Journal of the American Heart Association. 2022; 11 (7). doi:

55. Souche E, Beltran S, Brosens E, et al. Recommendations for Whole Genome Sequencing in Diagnostics for Rare Diseases. European Journal of Human Genetics. 2022; 30 (9):1017-1021. doi:

56. Alekhya Narravula, Garber KB, S. Hussain Askree, Hegde M, Hall PL. Variants of uncertain significance in newborn screening disorders: implications for large-scale genomic sequencing. Genetics in Medicine. 2017; 19 (1):77-82. doi: 10.1038/gim.2016.67

57. Malas M, Aboalfaraj A, Alamoudi H, Kurdi A, Alahmadi T, Zawawi F. Pediatricians’ knowledge and attitude toward hearing loss and newborn hearing screening programs. International Journal of Pediatric Otorhinolaryngology. 2022; 161: 111265. doi:

58. Mongkonsritragoon W, Huang J, Fredrickson M, Seth D, Pavadee Poowuttikul. Positive Newborn Screening for Severe Combined Immunodeficiency: What Should the Pediatrician Do? Clinical Medicine Insights in Pediatrics. 2023; 17:117955652311628-117955652311628. doi:

59. Weismiller DG. Expanded Newborn Screening: Information and Resources for the Family Physician. PubMed. 2017; 95(11):703-709.

60. Watson MS, Lloyd-Puryear MA, Howell RR. The Progress and Future of US Newborn Screening. International Journal of Neonatal Screening. 2022; 8 (3):41. doi:

61. Wilson J, Junger G, World Health Organization. World Health Organization (WHO). Published 1968. Accessed August 20, 2023. /10665/37650

62. Watson MS, Mann MY, Lloyd-Puryear MA, Rinaldo P, Howell RR. Executive Summary. Genetics in Medicine. 2006; 8: S1-S11. doi:

63. Kemper AR, Green NS, Calonge N, et al. Decision-making process for conditions nominated to the Recommended Uniform Screening Panel: statement of the US Department of Health and Human Services Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children. Genetics in Medicine. 2013; 16(2):183-187. doi: